(Q41144806)
English
An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin K antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary interv
scientific article published on 20 December 2014
- An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin k antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary interve
Statements
1 reference
An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin K antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary interv (English)
1 reference
Gregory Y H Lip
1 reference
Christoph Bode
1 reference
Eric Peterson
1 reference
Freek Verheugt
1 reference
C Michael Gibson
1 reference
Johnathan Halperin
1 reference
Peter Wildgoose
1 reference
Martin van Eickels
1 reference
Marc Cohen
1 reference
Steen Husted
1 reference
Keith Fox
1 reference
20 December 2014
1 reference
1 reference
Identifiers
1 reference